Vita Coco Company, Inc. (COCO) director reports stock sale and options

Rhea-AI Filing Summary

Vita Coco Company, Inc. director Kenneth Sadowsky reported selling 3,900 shares of common stock on 12/17/2025 at a weighted average price of $51.621 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to trade according to a preset schedule.

After this transaction, Sadowsky beneficially owns 612,166 shares of Vita Coco common stock directly. He also holds a fully vested, currently exercisable non-qualified stock option to buy 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on 01/02/2030.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sadowsky Kenneth

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		S(1)		3,900	D	$51.621(2)	612,166	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(3)	01/02/2030	Common Stock	27,300		27,300	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.24 to $52.23, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The stock option is fully vested and currently exercisable.

	By: Alison Klein, Attorney-in-Fact For: Kenneth Sadowsky	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vita Coco (COCO) report for Kenneth Sadowsky?

Vita Coco reported that director Kenneth Sadowsky sold 3,900 shares of common stock on 12/17/2025 at a weighted average price of $51.621 per share.

Was the Vita Coco (COCO) director’s stock sale made under a Rule 10b5-1 plan?

Yes. The filing states that the sales were effected pursuant to a Rule 10b5-1 trading plan, which is a pre-arranged plan for buying or selling shares.

How many Vita Coco (COCO) shares does Kenneth Sadowsky own after the reported sale?

Following the reported transaction, Kenneth Sadowsky beneficially owns 612,166 shares of Vita Coco common stock directly.

What was the price range for the Vita Coco (COCO) shares sold by the director?

The weighted average sale price was $51.621 per share. The filing notes that the shares were sold in multiple transactions at prices ranging from $51.24 to $52.23, inclusive.

What stock options related to Vita Coco (COCO) does Kenneth Sadowsky hold?

He holds a non-qualified stock option to buy 27,300 shares of Vita Coco common stock at an exercise price of $10.178 per share. The option is fully vested, currently exercisable, and expires on 01/02/2030.

What is Kenneth Sadowsky’s role at Vita Coco (COCO)?

The filing identifies Kenneth Sadowsky as a director of Vita Coco Company, Inc.